Earnings Preview: Agios Pharmaceuticals
Portfolio Pulse from Benzinga Insights
Agios Pharmaceuticals (NASDAQ:AGIO) is set to release its quarterly earnings report on October 31, 2024. Analysts expect an EPS of $-1.01. The company's past performance shows a tendency for share price drops following earnings misses. Analysts rate Agios as 'Outperform' with a price target suggesting a 14.46% upside. However, Agios ranks low among peers in revenue growth, gross profit, and return on equity.
October 30, 2024 | 2:03 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Agios Pharmaceuticals is expected to report an EPS of $-1.01. Analysts rate it 'Outperform' with a potential 14.46% upside. Past earnings misses have led to share price drops. Investors should watch for guidance.
Agios Pharmaceuticals is releasing its earnings report soon, with analysts expecting an EPS of $-1.01. The company's past performance shows a pattern of share price drops following earnings misses. However, the 'Outperform' rating and potential upside suggest positive sentiment. The market will likely react based on whether Agios meets or exceeds expectations and the guidance provided.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100